Rotasiil疫苗对刚果民主共和国轮状病毒相关住院的疫苗效果:在检测阴性设计中比较多变量逻辑回归与逆概率治疗加权方法
在刚果民主共和国金沙萨两家医院2020年1月1日至2023年12月31日的检测阴性设计中,纳入310名6至30月龄儿童分析Rotasiil疫苗效果。全程接种对比未接种的疫苗效果,多变量逻辑回归为60%(95%CI:20-80),逆概率治疗加权为79%(95%CI:71-85);两种方法置信区间重叠,效果估计无统计学差异且方法互补。
要点
- 检测阴性设计纳入310名6至30月龄儿童,其中118名(38%)轮状病毒阳性。
- 全程接种对比未接种的疫苗效果:多变量逻辑回归60%(95%CI:20-80),逆概率治疗加权79%(95%CI:71-85)。
- 逆概率治疗加权估计比多变量逻辑回归更精确,但置信区间重叠,提示效果估计无统计学差异且方法互补。
核心结论
- Rotasiil疫苗在常规使用条件下有效减少儿童轮状病毒相关腹泻住院,支持继续使用轮状病毒疫苗。
研究设计与样本
- 采用检测阴性病例对照设计,分析刚果民主共和国金沙萨两家医院2020年1月1日至2023年12月31日的哨点监测数据,对象为因急性腹泻就诊的59月龄及以下儿童。
- 全程轮状病毒疫苗剂量分析共纳入310名6至30月龄儿童,其中118名(38%)轮状病毒阳性,全程接种比例为87%,中位年龄10月龄(范围:8-14)。
主要发现
- 全程接种对比未接种的疫苗效果,多变量逻辑回归为60%(95%CI:20-80),逆概率治疗加权为79%(95%CI:71-85)。
- 逆概率治疗加权的疫苗效果估计比多变量逻辑回归更精确,但两者置信区间重叠,提示效果估计无统计学差异且方法互补。
临床怎么用
- 原文结论支持继续使用轮状病毒疫苗,未给出其他具体临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multinational rotavirus vaccines (Rotarix and RotaTeq) are 43 %-65 % effective in preventing hospitalizations due to rotavirus disease in African countries. The Rotasiil vaccine (Serum Institute of India) offers a potentially cost-effective option but lacks vaccine effectiveness (VE) estimates in African settings. We estimated Rotasiil VE against rotavirus hospitalizations in the Democratic Republic of Congo (DRC) using unconditional multivariate logistic regression and inverse probability of treatment weighting (IPTW) to adjust confounding. METHODS: We examined sentinel surveillance data from two hospitals in Kinshasa (January 1, 2020 to December 31, 2023) for children aged ≤59 months who sought care for acute diarrhea. We used a test-negative case-control design and calculated VE as [1 - adjusted odds ratio (OR) × 100] using unconditional multivariate logistic regression. We compared two approaches to adjust the OR for confounding. First, the OR was adjusted by including the covariates in the model. Second, the OR was adjusted using stabilized IPTW. RESULTS: In total, 310 children aged 6 to 30 months were included in the full rotavirus vaccine dose analysis, of which 118 (38 %) were rotavirus positive. The median age was 10 months (range: 8-14), and the proportion of fully vaccinated children was 87 %. The VE measured between fully vaccinated versus unvaccinated children was 60 % (95 % CI: 20-80) by multivariate logistic regression and 79 % (95 % CI: 71-85) by IPTW. CONCLUSION: Rotasiil vaccination under conditions of routine use effectively reduces rotavirus-associated diarrhea hospitalizations among children, supporting the ongoing use of rotavirus vaccine. The IPTW VE estimate was more precise than multivariate logistic regression but the confidence intervals overlapped, suggesting that the resulting VE estimates are not statistically different and the methods are complementary.
引用
- Luhata Lungayo C, Burnett E, Mulumba A, et al. Rotasiil vaccine effectiveness against rotavirus-associated hospitalizations in the Democratic Republic of the Congo: comparison of multivariate logistic regression and inverse probability treatment weighting methods in a test-negative design. Vaccine. 2025. PMID: 41218304. doi:10.1016/j.vaccine.2025.127944
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。